Authors
Loading...
In vitro and clinical studies reveal that RHOA lactylation enhances tumor progression in breast cancer, suggesting metabolic reprogramming may drive oncogenic activity.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: